Uncategorized
STAAR Surgical Reports Second Quarter 2020 Results
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended July 3, 2020. Second Quarter 2020 Overview Net Sales of $35.2 Million Down 11% from the Prior Year Quarter ICL Sales of $30.7 Million Down 11% and Units Down 3% from the Prior Year Quarter Gross Margin at 69.4% vs. 75.4% in the Prior Year Quarter